日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Increased treatment options and improved survival in real-world patients with HER2-positive advanced gastric cancer from 2011 to 2023

2011年至2023年，HER2阳性晚期胃癌患者的真实世界治疗选择增加，生存率提高。

期刊:
影响因子:
doi:10.1177/17562848261441026
Shimozaki, Keitaro; Ooki, Akira; Yoshikawa, Kaoru; Yoshino, Koichiro; Udagawa, Shohei; Osumi, Hiroki; Fukuoka, Shota; Wakatsuki, Takeru; Ogura, Mariko; Takahari, Daisuke; Shinozaki, Eiji; Chin, Keisho; Yamaguchi, Kensei
胃癌
肿瘤
肿瘤免疫
HER2
发表日期：2026
文献求助 收藏

Semiquantitative CLDN18 expression and clinical outcomes in patients with CLDN18-positive gastric cancer treated with zolbetuximab plus chemotherapy

半定量CLDN18表达与接受佐贝妥昔单抗联合化疗治疗的CLDN18阳性胃癌患者的临床结局

期刊:
影响因子:
doi:10.1016/j.esmogo.2026.100304
Ooki, A; Nakano, K; Shimozaki, K; Takamatsu, M; Fukuoka, S; Sakata, S; Osumi, H; Yoshikawa, K; Toyokawa, E; Yoshino, K; Udagawa, S; Wakatsuki, T; Ogura, M; Shinozaki, E; Chin, K; Kawachi, H; Yamaguchi, K
胃癌
CLDN1
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

BevRam-GC01 study protocol: a phase I trial of bevacizumab plus ramucirumab and paclitaxel in advanced gastric cancer

BevRam-GC01 研究方案：贝伐珠单抗联合雷莫芦单抗和紫杉醇治疗晚期胃癌的 I 期临床试验

期刊:
影响因子:
doi:10.1016/j.esmogo.2025.100299
Wakatsuki, T; Mashima, T; Miyazaki, N; Osumi, H; Fukuoka, S; Ooki, A; Shimozaki, K; Ogura, M; Yoshino, K; Udagawa, S; Shinozaki, E; Chin, K; Ishida, N; Seimiya, H; Yamaguchi, K
胃癌
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Investigating the role of immunotherapy for real-world patients with HER2-negative advanced gastric cancer between 2011 and 2023

调查免疫疗法在2011年至2023年间对HER2阴性晚期胃癌患者的真实世界治疗中的作用

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359251322670
Shimozaki, Keitaro; Ooki, Akira; Yoshino, Koichiro; Tamba, Mikako; Udagawa, Shohei; Osumi, Hiroki; Fukuoka, Shota; Nakayama, Izuma; Wakatsuki, Takeru; Ogura, Mariko; Takahari, Daisuke; Shinozaki, Eiji; Chin, Keisho; Yamaguchi, Kensei
胃癌
肿瘤
肿瘤免疫
HER2
免疫/内分泌
发表日期：2025
文献求助 收藏

Clinical relevance of circulating tumor DNA in HER2-positive advanced gastric cancer: a collaborative study of a phase Ib trial of dual HER2 and PD-1 targeted therapy (Ni-High)

循环肿瘤DNA在HER2阳性晚期胃癌中的临床意义：一项双重HER2和PD-1靶向治疗Ib期试验的合作研究（Ni-High）

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359251367344
Osumi, Hiroki; Wakatsuki, Takeru; Ooki, Akira; Chin, Keisho; Shoji, Hirokazu; Ogura, Mariko; Nakayama, Izuma; Yamamoto, Noriko; Hirano, Hidekazu; Hara, Hiroki; Minashi, Keiko; Shinozaki, Eiji; Kato, Ken; Ishizuka, Naoki; Kitano, Shigehisa; Takeuchi, Kengo; Boku, Narikazu; Yamaguchi, Kensei; Takahari, Daisuke
胃癌
肿瘤
HER2
肿瘤免疫
PD-1
发表日期：2025
文献求助 收藏

Phase I study of pevonedistat combined with capecitabine and oxaliplatin in patients with platinum-refractory advanced gastric cancer.

pevonedistat联合卡培他滨和奥沙利铂治疗铂类耐药晚期胃癌患者的I期研究。

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-30367-w
Shoji Hirokazu, Takahari Daisuke, Ooki Akira, Hirano Hidekazu, Okita Natsuko, Nagashima Kengo, Adachi Jun, Yamaguchi Kensei, Kato Ken, Boku Narikazu
胃癌
肿瘤
TAT
发表日期：2025
文献求助 收藏

Artificial Intelligence in Clinical Oncology: From Productivity Enhancement to Creative Discovery

人工智能在临床肿瘤学中的应用：从提高生产力到创造性发现

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol32110588
Kuno, Masahiro; Osumi, Hiroki; Udagawa, Shohei; Yoshikawa, Kaoru; Ooki, Akira; Shinozaki, Eiji; Ishikawa, Tetsuo; Oba, Junna; Yamaguchi, Kensei; Sakurada, Kazuhiro
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Real-world safety and efficacy of neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy for locally advanced esophageal squamous cell carcinoma

新辅助多西他赛、顺铂和5-氟尿嘧啶治疗局部晚期食管鳞状细胞癌的真实世界安全性和有效性

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-14011-4
Tamba, Mikako; Osumi, Hiroki; Ogura, Mariko; Fukuoka, Shota; Okamura, Akihiko; Kanamori, Jun; Imamura, Yu; Yoshino, Koichiro; Udagawa, Shohei; Wakatsuki, Takeru; Shinozaki, Eiji; Watanabe, Masayuki; Yamaguchi, Kensei; Chin, Keisho; Ooki, Akira
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Safety and efficacy of zolbetuximab plus chemotherapy for claudin 18 isoform 2-positive advanced gastric cancer: initial report of real-world experience

佐贝妥昔单抗联合化疗治疗 Claudin 18 同工型 2 阳性晚期胃癌的安全性和有效性：真实世界经验的初步报告

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-025-06406-4
Shimozaki, Keitaro; Ooki, Akira; Fukuoka, Shota; Osumi, Hiroki; Yoshikawa, Kaoru; Yoshino, Koichiro; Udagawa, Shohei; Wakatsuki, Takeru; Shinozaki, Eiji; Ogura, Mariko; Chin, Keisho; Yamaguchi, Kensei
胃癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Early Higher Plasma Regorafenib Concentration Predicts Shorter PFS in Japanese Patients With mCRC

早期血浆瑞戈非尼浓度升高预示着日本转移性结直肠癌患者的无进展生存期较短

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70386
Kobayashi, Kazuo; Wakatsuki, Takeru; Sugiyama, Erika; Shinozaki, Eiji; Tajima, Masataka; Ogura, Mariko; Chin, Keisho; Ooki, Akira; Osumi, Hiroki; Fukuoka, Shota; Udagawa, Shohei; Shimozaki, Keitaro; Aoyama, Takeshi; Nakano, Yasuhiro; Kawakami, Kazuyoshi; Suzuki, Wataru; Yokokawa, Takashi; Sato, Hitoshi; Yamaguchi, Masakazu; Yamaguchi, Kensei
肿瘤
肠癌
肿瘤免疫
发表日期：2025
文献求助 收藏